HEADER MEMBRANE PROTEIN 28-OCT-20 7ASY TITLE TRANSMEMBRANE HELIX OF TUMOR NECROSIS FACTOR ALPHA IN TRIFLUORETHANOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR NECROSIS FACTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CACHECTIN,TNF-ALPHA,TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY COMPND 5 MEMBER 2,TNF-A; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS TRANSMEMBRANE DOMAIN, HELIX, TRIFLUORETHANOL, MEMBRANE PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR N.GUSCHTSCHIN-SCHMIDT,C.MUHLE-GOLL REVDAT 2 23-DEC-20 7ASY 1 JRNL REVDAT 1 09-DEC-20 7ASY 0 JRNL AUTH C.SPITZ,C.SCHLOSSER,N.GUSCHTSCHIN-SCHMIDT,W.STELZER,S.MENIG, JRNL AUTH 2 A.GOTZ,M.HAUG-KROPER,C.SCHARNAGL,D.LANGOSCH,C.MUHLE-GOLL, JRNL AUTH 3 R.FLUHRER JRNL TITL NON-CANONICAL SHEDDING OF TNF ALPHA BY SPPL2A IS DETERMINED JRNL TITL 2 BY THE CONFORMATIONAL FLEXIBILITY OF ITS TRANSMEMBRANE JRNL TITL 3 HELIX. JRNL REF ISCIENCE V. 23 01775 2020 JRNL REFN ESSN 2589-0042 JRNL PMID 33294784 JRNL DOI 10.1016/J.ISCI.2020.101775 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 2 REMARK 3 AUTHORS : LINGE, O'DONOGHUE AND NILGES REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ASY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1292111990. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 0.5 MM TNFA_WT_TM, REMARK 210 TRIFLUOROETHANOL/WATER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 2D 1H-13C HSQC ALIPHATIC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.2, CCPNMR ANALYSIS REMARK 210 2.4.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 30 -148.64 -92.15 REMARK 500 1 GLN A 59 102.83 59.97 REMARK 500 2 CYS A 30 -148.23 -98.89 REMARK 500 2 ILE A 56 76.75 -105.50 REMARK 500 2 PRO A 58 93.42 -56.60 REMARK 500 3 CYS A 30 -148.29 -66.81 REMARK 500 4 CYS A 30 -148.51 -95.03 REMARK 500 4 GLN A 59 176.57 61.64 REMARK 500 5 CYS A 30 -148.09 -77.21 REMARK 500 6 CYS A 30 -148.47 -88.66 REMARK 500 6 GLN A 59 -158.15 42.25 REMARK 500 7 CYS A 30 -148.90 -88.08 REMARK 500 7 ILE A 56 -67.32 -131.51 REMARK 500 7 GLN A 59 93.26 -66.17 REMARK 500 8 CYS A 30 -148.89 -97.30 REMARK 500 9 CYS A 30 -151.10 -79.82 REMARK 500 10 CYS A 30 -148.57 -91.53 REMARK 500 10 GLN A 59 79.18 52.80 REMARK 500 11 CYS A 30 -149.32 -71.81 REMARK 500 11 VAL A 55 -77.87 59.49 REMARK 500 12 CYS A 30 -148.68 -99.59 REMARK 500 12 ILE A 56 -75.65 -79.98 REMARK 500 12 GLN A 59 41.82 -97.91 REMARK 500 13 CYS A 30 -148.63 -98.19 REMARK 500 14 CYS A 30 -148.54 -98.01 REMARK 500 14 VAL A 55 29.74 36.66 REMARK 500 15 CYS A 30 -151.94 -100.39 REMARK 500 15 PRO A 58 106.06 -57.65 REMARK 500 16 CYS A 30 -149.88 -70.68 REMARK 500 16 ILE A 56 -73.04 -126.02 REMARK 500 16 GLN A 59 17.53 59.22 REMARK 500 17 CYS A 30 -149.19 -99.28 REMARK 500 18 CYS A 30 -148.51 -99.45 REMARK 500 19 CYS A 30 -149.21 -100.22 REMARK 500 20 CYS A 30 -148.79 -99.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34567 RELATED DB: BMRB REMARK 900 TRANSMEMBRANE HELIX OF TUMOR NECROSIS FACTOR ALPHA IN REMARK 900 TRIFLUORETHANOL DBREF 7ASY A 28 60 UNP P01375 TNFA_HUMAN 28 60 SEQRES 1 A 33 ARG ARG CYS LEU PHE LEU SER LEU PHE SER PHE LEU ILE SEQRES 2 A 33 VAL ALA GLY ALA THR THR LEU PHE CYS LEU LEU HIS PHE SEQRES 3 A 33 GLY VAL ILE GLY PRO GLN ARG HELIX 1 AA1 LEU A 31 PHE A 36 1 6 HELIX 2 AA2 PHE A 36 GLY A 54 1 19 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1